Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
Multiple sclerosis, cannabis, and cognition: A structural MRI study.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Labor induction and augmentation in women with multiple sclerosis.
B-cell-directed therapy: which B cells should be targeted and how?
Nrf2 in health and disease: current and future clinical implications.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity.
Change of fate commitment in adult neural progenitor cells subjected to chronic inflammation.
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
A Mushroom Extract Piwep from Phellinus igniarius Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Immune Cell Infiltration in the Spinal Cord.
HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
Pages
« first
‹ previous
…
205
206
207
208
209
210
211
212
213
…
next ›
last »